When you think of high-stakes betting, you probably don’t think of spelling bees. Continue reading
173 men. 173 mustaches. $308,000 raised for charity.
How do mustaches translate into doing good? It all started with a pair of friends, Dave Hogan and Aaron Breed, who shared the same two passions: mustaches and helping the children of Richmond, Virginia. Continue reading
In early December, Carimus co-founder Tony Pease appeared on WRAL TechWire’s Tech on Tap podcast to discuss the origins of the company’s GoodBookey app, the popularity of the app in light of new legalization initiatives in sports gambling, and the future of linking technology applications to social impact. Continue reading
What a thrill for the GoodBookey team last week, as we experienced our first Consumer Electronics Show in Las Vegas. Bigger and better than ever, CES now seems to transcend consumer electronics in our evolving world where the lines between technology and everyday life blur more by the day. Continue reading
Last week had a few mild upsets and came close to having some major drama. This week is full of rivalry games, but how many represent a legitimate chance at high point values? Better yet, what even odds games have the best chances at 200 or 300 points? Keep reading for Dr. Jason Senkbeil’s expert advice aka your best shot at winning a Phat Scooter!
There were ten potential upsets last week, but as expected only one hit. Wake somehow managed to beat NC State on the road. Most of the participants hit one to two 200 point values mixed with a few 100 pointers producing very modest scores last week. This week is the calm week before rivalry showdown weekend next week. That means we have several opportunities to break the 2875 point upset record when Old Dominion beat Va Tech.
Sometimes when you look at a seemingly ubiquitous charity behemoth like the American Cancer Society, you find that there’s so much more to know than you realized.
The ACS, founded 105 years ago by ten doctors and five laypeople in New York City, has perhaps had the biggest impact on cancer research and the advance of treatments of any single entity except the US government. Continue reading